Coeptis Therapeutics、Z Squared宣布合并协议

2025-04-25 21:08

Coeptis Therapeutics (NASDAQ:COEP) and Z Squared have entered into a definitive merger agreement that will result in Z Squared becoming a wholly-owned subsidiary of Coeptis.
Under the terms of the merger agreement, a wholly-owned subsidiary of Coeptis will merge with and into Z Squared and the holders of the outstanding Z Squared shares will receive equity in Coeptis in exchange for 9,000 U.S. based dogecoin mining machines at closing.
The combined company will focus on advancing Z Squared’s digital asset mining expertise, which focuses primarily on generating Dogecoin along with other digital assets. It will be led by Z Squared executives, David Halabu as chief executive officer and Michelle Burke as chief operating officer.
In connection with the merger, Coeptis intends to spin out its biopharmaceutical operations, and continue to operate those operations separately.
Source: Press Release

More on Coeptis Therapeutics